Saudi Arabia Biosimilars Market (2024-2030) Outlook | Trends, Forecast, Share, Size, Companies, Value, Industry, Analysis, Growth & Revenue

Market Forecast By Product (Insulin, Follitropin, Calcitonin, Glucagon, Teriparatide, Others), By Indication (Oncology, Offsite Treatment, Chronic Disorders, Blood Disorders, Infectious Diseases, Others), By Manufacturing (Outsourced, In-house) And Competitive Landscape
Product Code: ETC069958 Publication Date: Jul 2023 Updated Date: Jan 2024 Product Type: Report
Publisher: 6Wresearch No. of Pages: 70 No. of Figures: 35 No. of Tables: 5

Saudi Arabia Biosimilars Market Synopsis

Biosimilars are biological products that are highly similar to approved reference biologic drugs in terms of safety, efficacy, and quality. They offer a more affordable alternative to expensive biologic medications and contribute to cost savings in healthcare systems.

Market Drivers

Biosimilars are often priced lower than their reference biologics, leading to cost savings for patients, healthcare providers, and the government. The prevalence of chronic diseases in Saudi Arabia, such as diabetes, cancer, and autoimmune disorders, drives the demand for affordable treatment options like biosimilars. The Saudi Arabia government`s initiatives to promote biosimilar adoption and encourage domestic production contribute to market growth.

Challenges of the Market

Obtaining regulatory approval for biosimilars can be a complex and time-consuming process, which may pose challenges for manufacturers. Building trust and acceptance among physicians and patients regarding the efficacy and safety of biosimilars is crucial for market growth.

Covid 19 Impact on the Market

The Covid-19 pandemic may have had varying impacts on the Saudi Arabia Biosimilars market. During the pandemic, disruptions in healthcare services and supply chains could have affected biosimilar availability and access. However, the pandemic`s focus on healthcare cost optimization and affordable treatment options may have accelerated interest in biosimilars.

key players of the Market

Some well-known companies involved in biosimilars production that have a presence in Saudi Arabia include, Sandoz International GmbH (a division of Novartis), Pfizer Inc., Amgen Inc., and Celltrion Inc.

Key Highlights of the Report:

  • Saudi Arabia Biosimilars Market Outlook
  • Market Size of Saudi Arabia Biosimilars Market, 2020
  • Forecast of Saudi Arabia Biosimilars Market, 2027
  • Historical Data and Forecast of Saudi Arabia Biosimilars Revenues & Volume for the Period 2023 - 2027
  • Saudi Arabia Biosimilars Market Trend Evolution
  • Saudi Arabia Biosimilars Market Drivers and Challenges
  • Saudi Arabia Biosimilars Price Trends
  • Saudi Arabia Biosimilars Porter's Five Forces
  • Saudi Arabia Biosimilars Industry Life Cycle
  • Historical Data and Forecast of Saudi Arabia Biosimilars Market Revenues & Volume By Product for the Period 2023 - 2027
  • Historical Data and Forecast of Saudi Arabia Biosimilars Market Revenues & Volume By Insulin for the Period 2023 - 2027
  • Historical Data and Forecast of Saudi Arabia Biosimilars Market Revenues & Volume By Follitropin for the Period 2023 - 2027
  • Historical Data and Forecast of Saudi Arabia Biosimilars Market Revenues & Volume By Calcitonin for the Period 2023 - 2027
  • Historical Data and Forecast of Saudi Arabia Biosimilars Market Revenues & Volume By Glucagon for the Period 2023 - 2027
  • Historical Data and Forecast of Saudi Arabia Biosimilars Market Revenues & Volume By Teriparatide for the Period 2023 - 2027
  • Historical Data and Forecast of Saudi Arabia Biosimilars Market Revenues & Volume By Others for the Period 2023 - 2027
  • Historical Data and Forecast of Saudi Arabia Biosimilars Market Revenues & Volume By Indication for the Period 2023 - 2027
  • Historical Data and Forecast of Saudi Arabia Biosimilars Market Revenues & Volume By Oncology for the Period 2023 - 2027
  • Historical Data and Forecast of Saudi Arabia Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2023 - 2027
  • Historical Data and Forecast of Saudi Arabia Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2023 - 2027
  • Historical Data and Forecast of Saudi Arabia Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2023 - 2027
  • Historical Data and Forecast of Saudi Arabia Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2023 - 2027
  • Historical Data and Forecast of Saudi Arabia Biosimilars Market Revenues & Volume By Others for the Period 2023 - 2027
  • Historical Data and Forecast of Saudi Arabia Biosimilars Market Revenues & Volume By Manufacturing for the Period 2023 - 2027
  • Historical Data and Forecast of Saudi Arabia Biosimilars Market Revenues & Volume By Outsourced for the Period 2023 - 2027
  • Historical Data and Forecast of Saudi Arabia Biosimilars Market Revenues & Volume By In-house for the Period 2023 - 2027
  • Saudi Arabia Biosimilars Import Export Trade Statistics
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By Manufacturing
  • Saudi Arabia Biosimilars Top Companies Market Share
  • Saudi Arabia Biosimilars Competitive Benchmarking By Technical and Operational Parameters
  • Saudi Arabia Biosimilars Company Profiles
  • Saudi Arabia Biosimilars Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Saudi Arabia Biosimilars Market Overview

3.1 Saudi Arabia Country Macro Economic Indicators

3.2 Saudi Arabia Biosimilars Market Revenues & Volume, 2020 & 2027F

3.3 Saudi Arabia Biosimilars Market - Industry Life Cycle

3.4 Saudi Arabia Biosimilars Market - Porter's Five Forces

3.5 Saudi Arabia Biosimilars Market Revenues & Volume Share, By Product, 2020 & 2027F

3.6 Saudi Arabia Biosimilars Market Revenues & Volume Share, By Indication, 2020 & 2027F

3.7 Saudi Arabia Biosimilars Market Revenues & Volume Share, By Manufacturing, 2020 & 2027F

4 Saudi Arabia Biosimilars Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Saudi Arabia Biosimilars Market Trends

6 Saudi Arabia Biosimilars Market, By Types

6.1 Saudi Arabia Biosimilars Market, By Product

6.1.1 Overview and Analysis

6.1.2 Saudi Arabia Biosimilars Market Revenues & Volume, By Product, 2018 - 2027F

6.1.3 Saudi Arabia Biosimilars Market Revenues & Volume, By Insulin, 2018 - 2027F

6.1.4 Saudi Arabia Biosimilars Market Revenues & Volume, By Follitropin, 2018 - 2027F

6.1.5 Saudi Arabia Biosimilars Market Revenues & Volume, By Calcitonin, 2018 - 2027F

6.1.6 Saudi Arabia Biosimilars Market Revenues & Volume, By Glucagon, 2018 - 2027F

6.1.7 Saudi Arabia Biosimilars Market Revenues & Volume, By Teriparatide, 2018 - 2027F

6.1.8 Saudi Arabia Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F

6.2 Saudi Arabia Biosimilars Market, By Indication

6.2.1 Overview and Analysis

6.2.2 Saudi Arabia Biosimilars Market Revenues & Volume, By Oncology, 2018 - 2027F

6.2.3 Saudi Arabia Biosimilars Market Revenues & Volume, By Offsite Treatment, 2018 - 2027F

6.2.4 Saudi Arabia Biosimilars Market Revenues & Volume, By Chronic Disorders, 2018 - 2027F

6.2.5 Saudi Arabia Biosimilars Market Revenues & Volume, By Blood Disorders, 2018 - 2027F

6.2.6 Saudi Arabia Biosimilars Market Revenues & Volume, By Infectious Diseases, 2018 - 2027F

6.2.7 Saudi Arabia Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F

6.3 Saudi Arabia Biosimilars Market, By Manufacturing

6.3.1 Overview and Analysis

6.3.2 Saudi Arabia Biosimilars Market Revenues & Volume, By Outsourced, 2018 - 2027F

6.3.3 Saudi Arabia Biosimilars Market Revenues & Volume, By In-house, 2018 - 2027F

7 Saudi Arabia Biosimilars Market Import-Export Trade Statistics

7.1 Saudi Arabia Biosimilars Market Export to Major Countries

7.2 Saudi Arabia Biosimilars Market Imports from Major Countries

8 Saudi Arabia Biosimilars Market Key Performance Indicators

9 Saudi Arabia Biosimilars Market - Opportunity Assessment

9.1 Saudi Arabia Biosimilars Market Opportunity Assessment, By Product, 2020 & 2027F

9.2 Saudi Arabia Biosimilars Market Opportunity Assessment, By Indication, 2020 & 2027F

9.3 Saudi Arabia Biosimilars Market Opportunity Assessment, By Manufacturing, 2020 & 2027F

10 Saudi Arabia Biosimilars Market - Competitive Landscape

10.1 Saudi Arabia Biosimilars Market Revenue Share, By Companies, 2020

10.2 Saudi Arabia Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All